Photoinactivation of Neisseria gonorrhoeae: A Paradigm-Changing Approach for Combating Antibiotic-Resistant Gonococcal Infection

Abstract

Antimicrobial resistance in Neisseria gonorrhoeae is a major issue of public health, and there is a critical need for the development of new antigonococcal strategies. In this study, we investigated the effectiveness of antimicrobial blue light (aBL; wavelength, 405 nm), an innovative nonpharmacological approach, for the inactivation of N. gonorrhoeae. Our findings indicated that aBL preferentially inactivated N. gonorrhoeae, including antibiotic-resistant strains, over human vaginal epithelial cells in vitro. Furthermore, no aBL-induced genotoxicity to the vaginal epithelial cells was observed at the radiant exposure used to inactivate N. gonorrhoeae. aBL also effectively inactivated N. gonorrhoeae that had attached to and invaded into the vaginal epithelial cells in their cocultures. No gonococcal resistance to aBL developed after 15 successive cycles of inactivation induced by subtherapeutic exposure to aBL. Endogenous aBL-activatable photosensitizing porphyrins in N. gonorrhoeae were identified and quantified using ultraperformance liquid chromatography, with coproporphyrin being the most abundant species in all N. gonorrhoeae strains studied. Singlet oxygen was involved in aBL inactivation of N. gonorrhoeae. Together, these findings show that aBL represents a potential potent treatment for antibiotic-resistant gonococcal infection.

Document Details

Document Type
Pub Defense Publication
Publication Date
Jan 09, 2019
Source ID
10.1093/infdis/jiz018

Entities

People

  • Jeffrey A. Gelfand
  • Kathryn D Held
  • Raquel Ferrer-Espada
  • Tianhong Dai
  • Xueping S Goh
  • Yan Baglo
  • Ying Gu
  • Ying Wang
  • Yonatan H Grad

Organizations

  • China Scholarship Council
  • Harvard Medical School
  • Harvard University
  • National Institutes of Health
  • National Natural Science Foundation of China
  • United States Department of Defense

Tags

Fields of Study

  • Biology

Readers

  • Archaeological Resource Survey
  • Infectious Disease/Epidemiology
  • Oncology (Cancer Research).